US Stock MarketDetailed Quotes

SCNI Scinai Immunotherapeutics

Watchlist
  • 3.000
  • -0.110-3.54%
Close Nov 12 16:00 ET
2.56MMarket Cap0.00P/E (TTM)

About Scinai Immunotherapeutics Company

Scinai Immunotherapeutics Ltd. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunomodulation therapies for infectious diseases. It focuses on the flu vaccine candidate that was designed to provide multi-strain and multi-season protection against seasonal and pandemic influenza. The company was founded by Ronald Babecoff and Rami Epstein on July 21, 2003 and is headquartered in Jerusalem, Israel.

Company Profile

SymbolSCNI
Company NameScinai Immunotherapeutics
Listing DateMay 12, 2015
Founded2003
CEOMr. Amir Reichman
MarketNASDAQ
Employees31
Securities TypeDR
ADS Ratio1.0 : 4000.0
Fiscal Year Ends12-31
AddressJerusalem BioPark,Hadassah Ein Kerem Campus,2nd Floor
CityJerusalem
ProvinceJerusalem
CountryIsrael
Zip Code74036
Phone972-302-930-2529
Websitehttp://www.scinai.com

Company Executives

  • Name
  • Position
  • Salary
  • Amir Reichman
  • Chief Executive Officer and Director
  • 927.00K
  • Uri Ben-Or
  • Chief Financial Officer
  • 174.00K
  • Dalit Weinstein Fischer
  • Chief Technology Officer
  • 232.00K
  • Elad Mark
  • Chief Operating Officer
  • 265.00K
  • Mark Germain
  • Chairman of the Board
  • 336.67K
  • Samuel J. Moed
  • Director
  • 493.15K
  • Dr. Yael Margolin, M.Sc.,PhD
  • Independent Director
  • 87.02K
  • Jay Green
  • Independent Director
  • 72.36K
  • Adi Raviv
  • Independent Director
  • 92.19K
  • Avner Rotman
  • Independent Director
  • 76.59K
  • Dr. Morris Laster, M.D.
  • Independent Director
  • 78.79K
  • Dr. Tamar Ben Yedidia
  • Chief Scientist
  • 297.00K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data